Zhejiang Jolly Pharmaceutical Co Ltd
Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kid… Read more
Zhejiang Jolly Pharmaceutical Co Ltd (300181) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.007x
Based on the latest financial reports, Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a cash flow conversion efficiency ratio of -0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-23.58 Million) by net assets (CN¥3.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Jolly Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Zhejiang Jolly Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Jolly Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Jolly Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nine Entertainment Co. Holdings Limited
PINK:NNMTF
|
0.106x |
|
Tatung Co
TW:2371
|
-0.009x |
|
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601
|
0.042x |
|
Triumph Science & Technology Co Ltd
SHG:600552
|
-0.016x |
|
Borr Drilling Ltd
NYSE:BORR
|
0.028x |
|
Net263 Ltd
SHE:002467
|
0.014x |
|
JVCKENWOOD Corporation
OTCGREY:JVCKF
|
0.075x |
|
Carel Industries S.p.A.
LSE:0YQA
|
0.078x |
Annual Cash Flow Conversion Efficiency for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.82 Billion | CN¥297.05 Million | 0.105x | +1.31% |
| 2023-12-31 | CN¥2.77 Billion | CN¥288.46 Million | 0.104x | -9.91% |
| 2022-12-31 | CN¥2.76 Billion | CN¥318.59 Million | 0.115x | -9.08% |
| 2021-12-31 | CN¥1.98 Billion | CN¥251.80 Million | 0.127x | -21.95% |
| 2020-12-31 | CN¥1.72 Billion | CN¥279.69 Million | 0.163x | +77.59% |
| 2019-12-31 | CN¥1.41 Billion | CN¥128.94 Million | 0.092x | +62.31% |
| 2018-12-31 | CN¥1.39 Billion | CN¥78.28 Million | 0.056x | +1192.59% |
| 2017-12-31 | CN¥1.49 Billion | CN¥6.51 Million | 0.004x | -88.98% |
| 2016-12-31 | CN¥1.47 Billion | CN¥58.30 Million | 0.040x | -41.45% |
| 2015-12-31 | CN¥1.44 Billion | CN¥97.13 Million | 0.068x | +330.67% |
| 2014-12-31 | CN¥871.76 Million | CN¥13.70 Million | 0.016x | -58.87% |
| 2013-12-31 | CN¥772.52 Million | CN¥29.50 Million | 0.038x | -11.63% |
| 2012-12-31 | CN¥705.92 Million | CN¥30.51 Million | 0.043x | +116.47% |
| 2011-12-31 | CN¥683.92 Million | CN¥13.65 Million | 0.020x | -93.61% |
| 2010-12-31 | CN¥207.17 Million | CN¥64.78 Million | 0.313x | +18.04% |
| 2009-12-31 | CN¥165.70 Million | CN¥43.89 Million | 0.265x | +26.77% |
| 2008-12-31 | CN¥149.11 Million | CN¥31.16 Million | 0.209x | +88.11% |
| 2007-12-31 | CN¥144.47 Million | CN¥16.05 Million | 0.111x | -- |